ROSALIND, a leader in extracting meaningful insights from diverse pools of life science data, today announced the commercial launch of its new solution for single cell data analysis. The new analysis module, which enables web-based collaboration and the analysis and interpretation of 10X Genomics-generated single cell data, is built on the company’s proven cloud-based platform that is well-known for its intuitive, fast, and easy-to-use tools for analyzing RNA-Seq, NanoString nCounter, as well as other data types. Formerly known as OnRamp Bio, ROSALIND also unveiled its new corporate brand as part of its presence at the virtual Advances in Genome Biology and Technology (AGBT) conference taking place March 1-3, 2021.
top of page
Search
Recent Posts
See AllBy: Steven Loeb Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times...
Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and...
Luna, the leading provider of in-home physical therapy, has teamed up with UCI Health, to expand access to patient care by providing...
bottom of page
Comments